Korro Bio, Inc.

The momentum for this stock is not very good. Korro Bio, Inc. is not a good value stock. Korro Bio, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Korro Bio, Inc..

News

Korro Bio, Inc. (NASDAQ:KRRO) Short Interest Update

Ticker Report Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) saw a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 295,000 shares, a growth of 5.1...\n more…

Korro Bio Board Changes and Strategic Advisor Agreement

TipRanks Financial Blog An announcement from Korro Bio (KRRO) is now available. David L. Lucchino resigned from our Board of Directors on August 26, 2024, but will stay connected as a stra...\n more…

Korro Bio appoints Katharine Knobil to board of directors

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Korro to Participate in Upcoming September Investor and Scientific Conferences

Globe Newswire CAMBRIDGE, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA...\n more…

Critical Survey: Korro Bio (NASDAQ:KRRO) & Lumos Pharma (NASDAQ:LUMO)

Ticker Report Korro Bio (NASDAQ:KRRO - Get Free Report) and Lumos Pharma (NASDAQ:LUMO - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two...\n more…

Korro Bio (NASDAQ:KRRO) Research Coverage Started at William Blair

Zolmax William Blair assumed coverage on shares of Korro Bio (NASDAQ:KRRO - Free Report) in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. The firm issued an...\n more…